Now scientists at the David Geffen School of Medicine at UCLA have deciphered how a naturally occurring gene mutation in rats' brains lowers the animals' tolerance to alcohol, leading to rapid and acute intoxication after the equivalent of one drink. The UCLA study is the first to identify how the gene variation alters GABA receptors -- specific sites targeted by chemicals from the brain cells -- making them more responsive to very low levels of alcohol. Alcohol enhances the GABA receptors' influence on brain cells, slowing the cells' activity and ability to communicate.
The fact that the gene mutation arises naturally suggests that tolerance levels to alcohol may be genetically wired in people, too. If so, the findings could eventually help identify children and adults at higher risk of developing alcohol dependency, so these individuals can make an informed decision about whether to drink. The study results may also speed the development of new drugs that target alcohol-sensitive GABA receptors, leading to better treatments for alcohol poisoning and addiction.
The Feb. 6 online edition of Nature Neuroscience reports the findings.
Source: University of California - Los Angeles
Related stories:
Alcohol consumption can cause too much cell death, fetal abnormalities
The initial signs of fetal alcohol syndrome are slight but classic: facial malformations such as a flat and high upper lip, small eye openings and a short nose.
MicroRNA implicated as molecular factor in alcohol tolerance
In recent years, a class of small molecules known as microRNA have been found to play an important role in regulating gene products in most animal and plant species. A new study now indicates that microRNA may influence the development of alcohol tolerance, a hallmark of alcohol abuse and dependence. Researchers supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) report the findings in the July 31 issue of the journal
Neuron.
Does Gene Variant Make Women More Prone to Alcoholism?
A particular gene variant might make women more susceptible to alcoholism. At least, a study carried out by the Universities of Bonn and Sweden’s Karolinska Institute makes this a plausible conclusion.
Gene therapy reduces cocaine use in rats
Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that increasing the brain level of receptors for dopamine, a pleasure-related chemical, can reduce use of cocaine by 75 percent in rats trained to self-administer it. Earlier research by this team had similar findings for alcohol intake. Treatments that increase levels of these chemicals - dopamine D2 receptors -- may prove useful in treating addiction, according to the authors. The study will be published online April 16 and will appear in the July 2008 issue of
Synapse.
Scientists find genetic factor in stress response variability
Inherited variations in the amount of an innate anxiety-reducing molecule help explain why some people can withstand stress better than others, according to a new study led by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH).
Brain DNA 'remodeled' in alcoholism
Reshaping of the DNA scaffolding that supports and controls the expression of genes in the brain may play a major role in the alcohol withdrawal symptoms, particularly anxiety, that make it so difficult for alcoholics to stop using alcohol.
Motor neuron disease and toxic substances: Possible link?
Motor neuron disease is a rare, devastating illness in which nerve cells that carry brain signals to muscles gradually deteriorate. One form of it, Lou Gehrig’s disease or ALS (amyotrophic lateral sclerosis), is familiar to the public in the lives of scientist Stephen Hawking and Morrie Schwartz, about whom Mitch Albom’s “Tuesdays with Morrie” was written.
Brain chemistry ties anxiety and alcoholism
Doctors may one day be able to control alcohol addiction by manipulating the molecular events in the brain that underlie anxiety associated with alcohol withdrawal, researchers at the University of Illinois at Chicago College of Medicine and the Jesse Brown VA Medical Center report in the March 5 issue of the Journal of Neuroscience.